| Basic Information | |
|---|---|
| Species | Fragaria vesca |
| Cazyme ID | mrna15520.1-v1.0-hybrid |
| Family | GT16 |
| Protein Properties | Length: 433 Molecular Weight: 49510.5 Isoelectric Point: 8.345 |
| Chromosome | Chromosome/Scaffold: 6 Start: 15313422 End: 15314720 |
| Description | beta-1,2-N-acetylglucosaminyltransferase II |
| View CDS | |
| Signature Domain Download full data set without filtering | |||
|---|---|---|---|
 | |||
| Family | Start | End | Evalue |
| GT16 | 86 | 423 | 0 |
| LEKRNQMPPRNLDLYPSLAKDHITVVLYVHNRPQYLKVAVDSISQVVGINETLLIVSHDGYFEEMNKIVEGIRFCQVKQIFAPFSPHVFPKGFPGVSPAD CKEKDDAAEKHCKGTPDQYGNHRLPKIVSLKHHWWWMMNTVWDGLDETRDHNGHILFIEEDHFLYPNAYQNLKILAALKPKKCPHCYAANLAPCDVTARG EGWDSLIAERMGNVGYTFNRTVWKKIHKKTSKFCFFDDYNWDITMWATVYPSFGNAVFTLRGPRTSAVHFGKCGLHQGQEGQKACIDNGVVNFQVEDVDK VANINPDWEVQVFENQPGYKAGFKGWGGWGDKRDHQLC | |||
| Full Sequence |
|---|
| Protein Sequence Length: 433 Download |
| MASNSSVTSK KQRLKDDASF RRFVSLASIT CLAVFLLVFL LRMNSSSNFE VPNSDEFDDV 60 LPRSYNRSLI SRRLNLPKQN KLSIELEKRN QMPPRNLDLY PSLAKDHITV VLYVHNRPQY 120 LKVAVDSISQ VVGINETLLI VSHDGYFEEM NKIVEGIRFC QVKQIFAPFS PHVFPKGFPG 180 VSPADCKEKD DAAEKHCKGT PDQYGNHRLP KIVSLKHHWW WMMNTVWDGL DETRDHNGHI 240 LFIEEDHFLY PNAYQNLKIL AALKPKKCPH CYAANLAPCD VTARGEGWDS LIAERMGNVG 300 YTFNRTVWKK IHKKTSKFCF FDDYNWDITM WATVYPSFGN AVFTLRGPRT SAVHFGKCGL 360 HQGQEGQKAC IDNGVVNFQV EDVDKVANIN PDWEVQVFEN QPGYKAGFKG WGGWGDKRDH 420 QLCLNFAQMY HL* |
| Functional Domains Download unfiltered results here | ||||||||
|---|---|---|---|---|---|---|---|---|
 | ||||||||
| Cdd ID | Domain | E-Value | Start | End | Length | Domain Description | ||
| pfam05060 | MGAT2 | 2.0e-178 | 83 | 423 | 364 | + N-acetylglucosaminyltransferase II (MGAT2). UDP-N-acetyl-D-glucosamine:alpha-6-D-mannoside beta-1,2-N- acetylglucosaminyltransferase II (EC 2.4.1.143) (GnT II/MGAT2) is a Golgi resident enzyme that catalyzes an essential step in the biosynthetic pathway leading from high mannose to complex N-linked oligosaccharides. Mutations in the MGAT2 gene lead to congenital disorder of glycosylation (CDG IIa). CDG IIa patients have an increased bleeding tendency, unrelated to coagulation factors. | ||
| Gene Ontology | |
|---|---|
| GO Term | Description |
| GO:0005795 | Golgi stack |
| GO:0008455 | alpha-1,6-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity |
| GO:0009312 | oligosaccharide biosynthetic process |
| GO:0016021 | integral to membrane |
